Leukopenia  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
PAVES, NCT00911170 / 2009-011899-30: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Checkmark ECC 2015
Sep 2015 - Sep 2015: ECC 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
3
847
US, Canada, Europe, RoW
Pegfilgrastim, Neulasta®, Placebo, Bevacizumab, Avastin®, Standard Chemotherapy
Amgen
Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
09/12
01/15

Download Options